These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 21271384)
21. Therapeutic targeting of polo-like kinase 1 using RNA-interfering nanoparticles (iNOPs) for the treatment of non-small cell lung cancer. McCarroll JA; Dwarte T; Baigude H; Dang J; Yang L; Erlich RB; Kimpton K; Teo J; Sagnella SM; Akerfeldt MC; Liu J; Phillips PA; Rana TM; Kavallaris M Oncotarget; 2015 May; 6(14):12020-34. PubMed ID: 25557168 [TBL] [Abstract][Full Text] [Related]
22. Combined gene expression profiling and RNAi screening in clear cell renal cell carcinoma identify PLK1 and other therapeutic kinase targets. Ding Y; Huang D; Zhang Z; Smith J; Petillo D; Looyenga BD; Feenstra K; Mackeigan JP; Furge KA; Teh BT Cancer Res; 2011 Aug; 71(15):5225-34. PubMed ID: 21642374 [TBL] [Abstract][Full Text] [Related]
23. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer. De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397 [TBL] [Abstract][Full Text] [Related]
24. Oncogenic effect of Polo-like kinase 1 expression in human gastric carcinomas. Jang YJ; Kim YS; Kim WH Int J Oncol; 2006 Sep; 29(3):589-94. PubMed ID: 16865274 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of polo-like kinase 1 leads to the suppression of osteosarcoma cell growth in vitro and in vivo. Liu X; Choy E; Harmon D; Yang S; Yang C; Mankin H; Hornicek FJ; Duan Z Anticancer Drugs; 2011 Jun; 22(5):444-53. PubMed ID: 21399492 [TBL] [Abstract][Full Text] [Related]
26. [Polo like kinase 1 expression and prognostic value in gastric carcinomas]. Lan B; Liu BY; Chen XH; Qu Y; Zhang XQ; Cai Q; Zhu ZG Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jan; 10(1):70-2. PubMed ID: 17253180 [TBL] [Abstract][Full Text] [Related]
27. RNAse A-like enzymes in serum inhibit the anti-neoplastic activity of siRNA targeting polo-like kinase 1. Haupenthal J; Baehr C; Zeuzem S; Piiper A Int J Cancer; 2007 Jul; 121(1):206-10. PubMed ID: 17351902 [TBL] [Abstract][Full Text] [Related]
28. Impact of anti-PLK1 siRNA-containing F3-targeted liposomes on the viability of both cancer and endothelial cells. Gomes-da-Silva LC; Ramalho JS; Pedroso de Lima MC; Simões S; Moreira JN Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):356-64. PubMed ID: 23659854 [TBL] [Abstract][Full Text] [Related]
29. Cancer Osaka thyroid (Cot) phosphorylates Polo-like kinase (PLK1) at Ser137 but not at Thr210. Wu B; Jiang P; Mu Y; Wilmouth RC Biol Chem; 2009 Dec; 390(12):1271-7. PubMed ID: 19804365 [TBL] [Abstract][Full Text] [Related]
30. PDK1 signaling toward PLK1-MYC activation confers oncogenic transformation, tumor-initiating cell activation, and resistance to mTOR-targeted therapy. Tan J; Li Z; Lee PL; Guan P; Aau MY; Lee ST; Feng M; Lim CZ; Lee EY; Wee ZN; Lim YC; Karuturi RK; Yu Q Cancer Discov; 2013 Oct; 3(10):1156-71. PubMed ID: 23887393 [TBL] [Abstract][Full Text] [Related]
31. [Interference of invasion and metastasis of colorectal cancer cells by EMS1-siRNA encoded by a recombinant lentiviral vector]. Qiu F; Zhu JW; Ma LL Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Nov; 14(11):887-91. PubMed ID: 22116727 [TBL] [Abstract][Full Text] [Related]
32. Overexpression of polo-like kinase 1 and its clinical significance in human non-small cell lung cancer. Wang ZX; Xue D; Liu ZL; Lu BB; Bian HB; Pan X; Yin YM Int J Biochem Cell Biol; 2012 Jan; 44(1):200-10. PubMed ID: 22064247 [TBL] [Abstract][Full Text] [Related]
33. Polo-like kinase 1 creates the tension-sensing 3F3/2 phosphoepitope and modulates the association of spindle-checkpoint proteins at kinetochores. Ahonen LJ; Kallio MJ; Daum JR; Bolton M; Manke IA; Yaffe MB; Stukenberg PT; Gorbsky GJ Curr Biol; 2005 Jun; 15(12):1078-89. PubMed ID: 15964272 [TBL] [Abstract][Full Text] [Related]
34. Polo-like kinase 1 is overexpressed in renal cancer and participates in the proliferation and invasion of renal cancer cells. Zhang G; Zhang Z; Liu Z Tumour Biol; 2013 Jun; 34(3):1887-94. PubMed ID: 23494182 [TBL] [Abstract][Full Text] [Related]
35. [Effect of semaphorin4D gene silencing on malignant behavior of human ovarian cancer SKOV3 cells]. Chen Y; Zhang L; Wu HJ; Liu WX; Hao Q Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):324-30. PubMed ID: 21875458 [TBL] [Abstract][Full Text] [Related]
36. Induction of antitumor immunity using dendritic cells electroporated with Polo-like kinase 1 (Plk1) mRNA in murine tumor models. Park JS; Sohn HJ; Park GS; Chung YJ; Kim TG Cancer Sci; 2011 Aug; 102(8):1448-54. PubMed ID: 21545375 [TBL] [Abstract][Full Text] [Related]
37. Effects of siRNA-targeting BMP-2 on the abilities of migration and invasion of human liver cancer SMMC7721 cells and its mechanism. Wu JB; Fu HQ; Huang LZ; Liu AW; Zhang JX Cancer Gene Ther; 2011 Jan; 18(1):20-5. PubMed ID: 20885449 [TBL] [Abstract][Full Text] [Related]
38. Expression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinoma. Kanaji S; Saito H; Tsujitani S; Matsumoto S; Tatebe S; Kondo A; Ozaki M; Ito H; Ikeguchi M Oncology; 2006; 70(2):126-33. PubMed ID: 16645325 [TBL] [Abstract][Full Text] [Related]
39. [Effect of PLK1 gene silence on cell cycle, proliferation and drug resistance in K562/A02 cells]. Liu L; Zhang M; Zou P; Tian L; Liu F Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):241-6. PubMed ID: 16638189 [TBL] [Abstract][Full Text] [Related]
40. Polo-like kinase-1 regulates first cleavage of one-cell embryos in culture during assisted reproduction. Zhao Y; Ai J; Zhang H; Zhu G Saudi Med J; 2010 Mar; 31(3):247-52. PubMed ID: 20231927 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]